Oxcarbazepine – place in the treatment of epilepsy
Medycyna Faktów · 2021
DOI: 10.24292/01.mf.0121.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medycyna Faktów, 2021. Verfasst von Marcin Kopka.
Abstract (Originalsprache)
Oxcarbazepine is recommended for the first line treatment of focal seizures in monotherapy and add-on therapy in both children and adults. It is well tolerated and less frequently interacts with other drugs, possible side effects less often lead to the cessation of the therapy. An important feature of the drug is a positive effect on the sexual sphere of patients and a presumed positive effect on reducing depressive symptoms.
Zitieren
APA
Kopka, M. (2021). Oxcarbazepine – place in the treatment of epilepsy. Medycyna Faktów. https://doi.org/10.24292/01.mf.0121.13
Vancouver
Kopka M. Oxcarbazepine – place in the treatment of epilepsy. Medycyna Faktów. 2021. doi:10.24292/01.mf.0121.13
BibTeX
@article{Kopka2021,
author = {Kopka, Marcin},
title = {Oxcarbazepine – place in the treatment of epilepsy},
journal = {Medycyna Faktów},
year = {2021},
doi = {10.24292/01.mf.0121.13}
}
EUVIMED